Published in TB and Outbreaks Week, November 2nd, 2004
But only a fraction of the 22.4 million doses that maker Aventis Pasteur has yet to ship can be diverted to areas with the biggest shortages. And officials acknowledged that even if planned rationing goes well, there will be high-risk patients who struggle to get shots but can't find them.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week